SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-001203
Filing Date
2024-02-14
Accepted
2024-02-14 14:06:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 rocksprings-acrs123123a4.htm SC 13G/A 108562
  Complete submission text file 0001172661-24-001203.txt   110166
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 24635894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

IRS No.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A